Sinopharm Group Co.-Unsp ADRSHTDY
13F holders, Q3 2024 (September 30)4holders +1
1new positions
0sold out
$13.10avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding Sinopharm Group Co.-Unsp ADR (SHTDY) in their 13F filings, up 1 from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($14K), Eagle Bay Advisors LLC ($4K) and PNC Financial Services Group, Inc. ($3K).
- Company
- Sinopharm Group Co.-Unsp ADR
- CUSIP
- 82937K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 296 shares bought and 108 shares sold, net +188 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Rhumbline Advisers | 0.00% | No change | 1,101 | $14K |
| Eagle Bay Advisors LLC | 0.00% | New | 294 | $4K |
| PNC Financial Services Group, Inc. | 0.00% | Add +0.9% | 223 | $3K |
| GAMMA Investing LLC | 0.00% | Reduce -34.5% | 205 | $3K |
"% of holder's portfolio" is SHTDY's weight in each manager's 13F, not the share of Sinopharm Group Co.-Unsp ADR the manager owns.